[{"NetIncomeLoss_3_Q3_USD":-111015000.0,"OtherAssetsNoncurrent_0_Q3_USD":41191000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":633059000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2311679000.0,"Liabilities_0_Q3_USD":1489317000.0,"GainLossOnInvestments_3_Q3_USD":10722000.0,"GainLossOnInvestments_1_Q3_USD":835000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":29450000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":5803000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-3448000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-34325000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-12147000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-33883000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":-12188000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":80750000.0,"ContractWithCustomerAssetNetCurrent_0_Q3_USD":38977000.0,"InterestPaidNet_3_Q3_USD":3700000.0,"PaymentsOfMergerRelatedCostsFinancingActivities_3_Q3_USD":1071000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":3086000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":8646000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":68447000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":215455000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":1376631000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1526000.0,"AssetsCurrent_0_Q3_USD":2536981000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":990000.0,"Depreciation_3_Q3_USD":9713000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":86628000.0,"IncomeTaxesPaid_3_Q3_USD":23532000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-19572000.0,"InventoryFinishedGoods_0_Q3_USD":950000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":12960000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-10970000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-34076000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-105297000.0,"NumberOfReportableSegments_3_Q3_Segment":2.0,"IncomeTaxExpenseBenefit_1_Q3_USD":2648000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-1047000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":126000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-122000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":139708000.0,"CommonStockValue_0_Q3_USD":140000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":139497000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":5803000.0,"MinorityInterest_0_Q3_USD":223235000.0,"EarningsPerShareBasic_3_Q3_USD":-0.8,"EarningsPerShareBasic_1_Q3_USD":-0.22,"InventoryRawMaterials_0_Q3_USD":17876000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-73970000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-3448000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":1497433000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_3_Q3_USD":358000.0,"InvestmentIncomeNet_3_Q3_USD":25913000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-31048000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-111225000.0,"IncreaseDecreaseInInventories_3_Q3_USD":1468000.0,"OtherAssetsCurrent_0_Q3_USD":146628000.0,"CostsAndExpenses_3_Q3_USD":588399000.0,"CostsAndExpenses_1_Q3_USD":196616000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q3_USD":170000.0,"MinorityInterestPeriodIncreaseDecrease_3_Q3_USD":-34325000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q3_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-75129000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.007,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q3_USD":12998000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_3_Q3_USD":29450000.0,"InvestmentIncomeNet_1_Q3_USD":6454000.0,"MinorityInterestPeriodIncreaseDecrease_1_Q3_USD":-12147000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-46264000.0,"CommonStockSharesIssued_0_Q3_shares":139793901.0,"ShareBasedCompensation_3_Q3_USD":135077000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":84100000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":22500000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q3_USD":225960000.0,"AmortizationOfFinancingCosts_3_Q3_USD":1884000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q3_USD":7000000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":12960000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":135077000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":45845000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_0_Q3_Investment":110.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-62085000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":139497000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":139708000.0,"InventoryWorkInProcess_0_Q3_USD":3346000.0,"LiabilitiesCurrent_0_Q3_USD":244571000.0,"AccountsPayableCurrent_0_Q3_USD":16222000.0,"InterestExpense_3_Q3_USD":33484000.0,"InterestExpense_1_Q3_USD":11321000.0,"NetIncomeLoss_1_Q3_USD":-30944000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":181518000.0,"NumberOfOperatingSegments_3_Q3_Segment":2.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":28274000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":1606384000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q3_USD":218960000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.22,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":170000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q3_USD":275000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_3_Q3_USD":357000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"AccruedIncomeTaxesCurrent_0_Q3_USD":8929000.0,"IncreaseDecreaseInContractWithCustomerAsset_3_Q3_USD":-24057000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":633059000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":5647000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.8,"CommonStockSharesOutstanding_0_Q3_shares":139793901.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-50228000.0,"InventoryNet_0_Q3_USD":22172000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":-23674000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":1696145000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":90548000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-40443000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-146387000.0,"StockRepurchasedAndRetiredDuringPeriodValue_3_Q3_USD":90550000.0,"OperatingIncomeLoss_1_Q3_USD":-36537000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":160079000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":438983000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q3_USD":307737000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":13195000.0,"OperatingIncomeLoss_3_Q3_USD":-149416000.0,"Assets_0_Q3_USD":3095701000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":104431000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":3095701000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-909098000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-7812000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":29971000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":429931000.0,"LongTermLoansFromBank_0_Q3_USD":59966000.0,"StockholdersEquity_0_Q3_USD":1383149000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-3475000.0,"ProfitLoss_1_Q3_USD":-43091000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":0.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":26912000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":45845000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":135077000.0,"IncreaseDecreaseInOtherEmployeeRelatedLiabilities_3_Q3_USD":-8967000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":28390000.0,"ProfitLoss_3_Q3_USD":-145340000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-139180000.0,"Ticker":"IONS","CIK":"874015","name":"IONIS PHARMACEUTICALS INC","OfficialName":"Ionis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"5803570258.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201104"}]